Hypothesis

Age‑related loss of bacterial enzymes that convert 5‑HTP to 5‑HI reduces luminal 5‑HI, diminishing L‑VDCC‑dependent calcium signaling in enterochromaffin (EC) cells. This shift drives EC senescence, increases serotonin reuptake via SERT, and lowers extracellular 5‑HT available to motility circuits, explaining why higher EC numbers coexist with poor gut motility in older individuals.

Mechanistic Rationale

1. Microbial 5‑HI as an EC activator – Bacteria‑derived 5‑HI opens L‑type VDCCs in colonic smooth muscle and, as shown in EC cultures, triggers calcium‑dependent serotonin release (see gut bacteria metabolize 5‑HTP to 5‑HI, which stimulates EC 5‑HT release and directly activates colonic smooth muscle contractility via L‑VDCCs).
2. Calcium signaling maintains EC homeostasis – Repeated calcium spikes activate CREB‑mediated transcription of genes that suppress the senescence‑associated secretory phenotype (SASP) and keep SERT expression low. When calcium influx falls, CREB activity drops, p16^INK4a^ rises, and ECs acquire a senescent state marked by tonic low‑level serotonin leak and heightened SERT uptake.
3. Aging microbiome shifts – With age, pro‑inflammatory taxa expand while SCFA‑ and 5‑HI‑producing strains decline (see aging alters microbiota toward pro‑inflammatory profiles, reducing protective SCFAs and barrier integrity). Consequently luminal 5‑HI falls, removing the calcium‑driven brake on EC senescence.
4. Net serotonergic output – Even though EC density rises in the ileum and colon of older humans (see EC cell numbers rise in the ileum of older humans, theorized to boost serotonin secretion, yet this links to altered gut motility), senescent ECs release less 5‑HT per cell and clear what is released more efficiently via SERT, yielding a net drop in serotonergic tone that drives dysmotility.

Testable Predictions

• Luminal 5‑HI concentrations are significantly lower in feces or mucosal lavage from aged mice (≥20 mo) versus young adults (3‑mo).
• Isolated ECs from aged tissue show reduced L‑VDCC‑mediated calcium transients in response to 5‑HI, increased p16^INK4a^ protein, and higher SERT mRNA/protein levels compared with young ECs.
• Oral administration of a colon‑targeted 5‑HI prodrug (or a 5‑HI‑producing probiotic) restores EC calcium signaling, lowers SERT expression, normalizes serotonin release per cell, and improves colonic transit in aged mice without altering EC numbers.
• Genetic ablation of L‑VDCC specifically in ECs phenocopies the aged EC secretory profile (low phasic 5‑HT, high SERT) and accelerates motility decline, even in young animals.

Experimental Approach

• Metabolite quantification: Use LC‑MS to measure 5‑HI in luminal contents from young and aged mice; confirm with human stool samples if available.
• EC functional assays: Isolate crypts, sort ECs via tryptophan hydroxylase 1 (TPH1)‑GFP reporter, perform Fluo‑4 calcium imaging with 5‑HI ± nifedipine (L‑VDCC blocker). Measure serotonin release by ELISA after depolarizing stimuli. Quantify SERT by qPCR and Western blot. Assess senescence via SA‑β‑gal staining and p16^INK4a^ immunofluorescence.
• Intervention: Feed aged mice a diet containing a pH‑dependent 5‑HI release capsule or administer a Lactobacillus strain engineered to express bacterial tryptophan hydroxylase and indole‑pyruvate decarboxylase pathways that yield 5‑HI. Monitor fecal water content, transit time (carmine red assay), and EC phenotypes after 2 weeks.
• Controls: Vehicle, non‑engineered probiotic, and L‑VDCC antagonist (nifedipine) groups.
• Statistical plan: Power analysis targeting 80 % power to detect 30 % change in transit time (α = 0.05). Use ANOVA with post‑hoc Tukey for multiple groups; correlations between luminal 5‑HI, EC calcium amplitude, and transit speed assessed via Pearson’s r.

If the data confirm that restoring 5‑HI rescues EC calcium dynamics, reduces SERT‑mediated uptake, and improves motility despite unchanged EC numbers, the hypothesis will be supported. Conversely, failure of 5‑HI supplementation to alter EC secretory phenotype or transit would falsify the proposed link between microbial 5‑HI loss, EC senescence, and age‑related dysmotility.